These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23222664)

  • 21. Psychosocial impact of predictive testing for Huntington disease on support persons.
    Williams JK; Schutte DL; Holkup PA; Evers C; Muilenburg A
    Am J Med Genet; 2000 Jun; 96(3):353-9. PubMed ID: 10898914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceed with care: direct predictive testing for Huntington disease.
    Benjamin CM; Adam S; Wiggins S; Theilmann JL; Copley TT; Bloch M; Squitieri F; McKellin W; Cox S; Brown SA
    Am J Hum Genet; 1994 Oct; 55(4):606-17. PubMed ID: 7942838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maturity of judgement in decision making for predictive testing for nontreatable adult-onset neurogenetic conditions: a case against predictive testing of minors.
    Richards FH
    Clin Genet; 2006 Nov; 70(5):396-401. PubMed ID: 17026621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes of persons at risk for Huntington disease toward predictive testing.
    Kessler S; Field T; Worth L; Mosbarger H
    Am J Med Genet; 1987 Feb; 26(2):259-70. PubMed ID: 2949610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Holding your breath": interviews with young people who have undergone predictive genetic testing for Huntington disease.
    Duncan RE; Gillam L; Savulescu J; Williamson R; Rogers JG; Delatycki MB
    Am J Med Genet A; 2007 Sep; 143A(17):1984-9. PubMed ID: 17663467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Informing about genetic risk in families with Huntington disease: comparison of attitudes across two decades.
    Pierron L; Hennessy J; Tezenas du Montcel S; Coarelli G; Heinzmann A; Schaerer E; Herson A; Petit E; Gargiulo M; Durr A
    Eur J Hum Genet; 2021 Apr; 29(4):672-679. PubMed ID: 33299145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Counselling for Predictive Testing in Huntington's Disease in One Centre since 1993. Gender-Specific Aspects of Decision-Making.
    Arning L; Witt CN; Epplen JT; Stemmler S
    J Huntingtons Dis; 2015; 4(1):87-98. PubMed ID: 26333260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic testing and mental health: the model of Huntington disease.
    Williams JK; Schutte DL
    Online J Issues Nurs; 2000; 5(3):3. PubMed ID: 11380269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presymptomatic testing for Huntington's disease.
    Bird SJ
    JAMA; 1985 Jun; 253(22):3286-91. PubMed ID: 3158756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the decision to take the predictive test for Huntington disease.
    Meissen GJ; Mastromauro CA; Kiely DK; McNamara DS; Myers RH
    Am J Med Genet; 1991 Jun; 39(4):404-10. PubMed ID: 1678928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatric morbidity associated with early clinical diagnosis of Huntington disease in a predictive testing program.
    Lam RW; Bloch M; Jones BD; Marcus AM; Fox S; Amman W; Hayden MR
    J Clin Psychiatry; 1988 Nov; 49(11):444-7. PubMed ID: 2972696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge, attitude, and the decision to be tested for Huntington's disease.
    Quaid KA; Brandt J; Faden RR; Folstein SE
    Clin Genet; 1989 Dec; 36(6):431-8. PubMed ID: 2531636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal testing in Huntington disease: after the test, choices recommence.
    Bouchghoul H; Clément SF; Vauthier D; Cazeneuve C; Noel S; Dommergues M; Héron D; Nizard J; Gargiulo M; Durr A
    Eur J Hum Genet; 2016 Nov; 24(11):1535-1540. PubMed ID: 27302844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethical dilemmas in testing for late onset conditions: reactions to testing and perceived impact on other family members.
    Chapman E
    J Genet Couns; 2002 Oct; 11(5):351-67. PubMed ID: 12625340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients' and Providers' Needs and Preferences When Considering Fertility Preservation Before Cancer Treatment: Decision-Making Needs Assessment.
    Hoffman A; Crocker L; Mathur A; Holman D; Weston J; Campbell S; Housten A; Bradford A; Agrawala S; Woodard TL
    JMIR Form Res; 2021 Jun; 5(6):e25083. PubMed ID: 34096871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negotiating responsibility: case studies of reproductive decision-making and prenatal genetic testing in families facing Huntington disease.
    Downing C
    J Genet Couns; 2005 Jun; 14(3):219-34. PubMed ID: 15959653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing a Decision-Aid Website for Breast Cancer Surgery: An Action Research Approach.
    Hung YT; Wu CF; Liang TH; Chou SS; Chen GL; Wu PN; Su GR; Jang TH; Liu CY; Wang CY; Tseng LM; Sheu SJ
    J Med Internet Res; 2019 Feb; 21(2):e10404. PubMed ID: 30714941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perception of predictive testing for Huntington's disease by young women: preferring uncertainty to certainty?
    Decruyenaere M; Evers-Kiebooms G; Van den Berghe H
    J Med Genet; 1993 Jul; 30(7):557-61. PubMed ID: 8411027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study.
    Anderson KE; Eberly S; Marder KS; Oakes D; Kayson E; Young A; Shoulson I;
    Clin Genet; 2019 Jul; 96(1):28-34. PubMed ID: 31093973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.